Summary & Overview
HCPCS G2160: Herpes Zoster Vaccination Receipt, Age 50+
HCPCS Level II code G2160 documents adult receipt of the herpes zoster vaccine series and serves as a preventive-care measure with implications for quality reporting and vaccine coverage tracking. The code captures patients who received at least one dose of the live vaccine or two doses of the recombinant vaccine (administered at least 28 days apart) any time on or after their 50th birthday, either before or during the measurement period. This designation supports monitoring of vaccine uptake among older adults and aligns with population health and immunization initiatives nationally.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication summarizes payer coverage patterns, coding and billing considerations, and clinical context relevant to herpes zoster vaccination for adults aged 50 and older.
Readers will learn where G2160 fits in preventive care reporting, typical sites of service for administering the vaccine, and how the code is used in quality measurement. The report also provides benchmarks and policy context where available and highlights gaps in input data when specific payer rules, associated taxonomies, ICD-10 pairings, or related codes are not provided. The content is designed for clinicians, billing specialists, and policy analysts seeking a concise, national overview of this HCPCS Level II vaccination code.
Billing Code Overview
HCPCS Level II code G2160 indicates that a patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) any time on or after the patient's 50th birthday before or during the measurement period.
Service Type: Vaccination / Immunization administration as part of preventive care for herpes zoster
Typical Site of Service: Outpatient clinics, primary care offices, pharmacies, and other ambulatory settings where adult immunizations are provided
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 64-year-old patient presents to a primary care clinic for a routine preventive care visit. The patient reports no prior receipt of the herpes zoster vaccine or is unsure of prior vaccination history. After review of immunization history and screening for contraindications (including severe allergy to vaccine components, pregnancy, or immunocompromise), the clinician documents eligibility for herpes zoster vaccination. For the recombinant vaccine series, the first dose is administered during the visit and the second dose is scheduled at least 28 days later; for the live vaccine, a single dose is administered if appropriate. The clinic documents vaccine lot number, administration route, anatomical site, and the date on the immunization record. The visit is coded with HCPCS Level II code G2160 to indicate the patient received at least one dose of the live vaccine or two doses of the recombinant vaccine on or after age 50 during the measurement period. Billing and claims staff append appropriate modifiers when needed (for unusual circumstances such as professional component issues, service discontinued, or payer-required modifier reporting) and submit the claim to payors including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare. Typical workflow includes patient screening, informed consent documentation, vaccine administration by a qualified provider (e.g., family medicine physician, internal medicine physician, nurse practitioner, or pharmacist where permitted), immunization recording in the electronic health record and state registry, and scheduling or verifying completion of the second dose for recombinant vaccine when applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|